LRRK2 and Parkinson disease: The PD pathogenic mutation G2019S increases kinase activity in both constructs by about the same factor (Figure 3C) whereas, it does not significantly affect GTPase activity in fl-LRRK2 but increases it in LRRK2RCKW to the same level as fl-LRRK2 (Figure 3B).